Levetiracetam in the Management of Bipolar Depression



Status:Completed
Conditions:Depression, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:October 2005
End Date:August 2008

Use our guide to learn which trials are right for you!

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the
effects of levetiracetam on depressive symptoms in bipolar depressed patients.


Inclusion Criteria:

- DSM-IV diagnosis of bipolar disorder

- Presence of a current major depressive episode on the SCID

- Score of 17 or great on the HDRS

- Capable of giving voluntary written consent

Exclusion Criteria:

- Significant current substance dependence/abuse within 3 months preceding the trial

- Active suicidal ideation

- Pregnant/lactating mothers

- Significant medical history
We found this trial at
1
site
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials